Clinical Trials

Showing 81 - 100 of 499 trials
Title Investigatorsort icon Disease(s)
A Phase II Study of MLN8237 in Patients with Advanced Prostate Cancer
[Protocol 13-042]
Danila, Daniel
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase I/II Study of Ipilimumab Given with Abiraterone and Prednisone in Men with Metastatic Castration-Resistant Prostate Cancer
[Protocol 12-120]
Danila, Daniel
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Pilot Trial of Enoxaparin versus Aspirin in Patients with Cancer and Stroke
[Protocol 12-264]
De Angelis, Lisa
  • Solid Tumors
A Phase III Study of Chemotherapy After Radiation in Young Patients with Newly Diagnosed Ependymoma
[Protocol 11-090]
De Braganca, Kevin
  • Pediatric Brain Tumors
    • Brain Cancer
    • CNS Cancer
A Phase II Study of Temozolomide plus Irinotecan with or without Bevacizumab in Children with Recurrent or Refractory Medulloblastoma or PNET
[Protocol 11-089]
De Braganca, Kevin
  • Pediatric Brain Tumors
    • Brain Cancer
A Pilot Study of Acupuncture to Control Symptoms in Patients Receiving Stem Cell Transplantation for Multiple Myeloma
[Protocol 13-038]
Deng, Gary
  • Blood & Marrow Stem Cell Transplantation
    • Autologous
  • Hematology
    • Multiple Myeloma
A Pilot Study of a Breathing Training Exercise to Reduce Chronic Shortness of Breath
[Protocol 12-261]
Deng, Gary
  • Lung Cancer
  • Survivorship
Prognostic Awareness and Patient-Physician Communication in Malignant Glioma
[Protocol 13-253]
Diamond, Eli
  • Brain Tumors, Primary
    • Gliomas
  • Quality of Life
A Phase III Study of Armodafinil versus Placebo to Reduce Cancer-Related Fatigue in Patients with High-Grade Glioma
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-040]
Diamond, Eli
  • Brain Tumors, Primary
    • Gliomas
  • Quality of Life
A Phase II Study of Fulvestrant Alone or with GDC-0941 or GDC-0980 in Women with Advanced Breast Cancer Resistant to Aromatase Inhibitor Therapy
[Protocol 12-029]
Dickler, Maura
  • Breast Cancer
Two Studies of GDC-0032: A Phase I Study of GDC-0032 for Solid Tumors with Increased PI3K Activity, and a Phase II Study of GDC-0032 with Fulvestrant in Patients with Advanced Breast Cancer
[Protocol 13-149]
Dickler, Maura
  • Breast Cancer
A Phase III Study of BKM120 with Fulvestrant in Postmenopausal Women with Locally Advanced or Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer
[Protocol 12-290]
Dickler, Maura
  • Breast Cancer
A Phase I Study of ARN-810 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
[Protocol 13-049]
Dickler, Maura
  • Breast Cancer
A Phase IB Study of LY2835219 plus Hormonal Therapy in Women with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
[Protocol 14-085]
Dickler, Maura
  • Breast Cancer
A Phase I Study of BYL719 with Letrozole or Exemestane for Treating Locally Advanced Inoperable or Metastatic Breast Cancer
[Protocol 13-027]
Dickler, Maura
  • Breast Cancer
A Pilot Trial of Bortezomib in Patients with Relapsed/Refractory AIDS-associated Kaposi Sarcoma
[Protocol 10-117]
Dickson, Mark
  • AIDS-Associated Cancers
    • AIDS-Associated Kaposi's Sarcoma
A Phase I Study of SAR405838 in Patients with Advanced Cancer
[Protocol 13-093]
Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
  • Solid Tumors
A Phase II Study of MLN8237 in Advanced or Metastatic Sarcoma
[Protocol 12-194]
Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of a Pediatric-Inspired Combination Chemotherapy Regimen in Adults with Acute Lymphoblastic Leukemia
[Protocol 12-266]
Douer, Dan
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I Study of BMS-906024 in Adult and Pediatric Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma
Relapsed/Refractory
[Protocol 11-181]
Douer, Dan
  • Leukemia
    • Acute Lymphoblastic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma